Literature DB >> 30886083

Multiplex targeted mass spectrometry assay for one-shot flavivirus diagnosis.

Sheena Wee1, Asfa Alli-Shaik1, Relus Kek2, Hannah L F Swa1, Wei-Ping Tien2, Vanessa W Lim3,4, Yee-Sin Leo3,4, Lee-Ching Ng2,5, Hapuarachchige C Hapuarachchi2, Jayantha Gunaratne6,7.   

Abstract

Targeted proteomic mass spectrometry is emerging as a salient clinical diagnostic tool to track protein biomarkers. However, its strong analytical properties have not been exploited in the diagnosis and typing of flaviviruses. Here, we report the development of a sensitive and specific single-shot robust assay for flavivirus typing and diagnosis using targeted mass spectrometry technology. Our flavivirus parallel reaction monitoring assay (fvPRM) has the ability to track secreted flaviviral nonstructural protein 1 (NS1) over a broad diagnostic and typing window with high sensitivity, specificity, extendibility, and multiplexing capability. These features, pivotal and pertinent to efficient response toward flavivirus outbreaks, including newly emerging flavivirus strains, circumvent the limitations of current diagnostic assays. fvPRM thus carries high potential in positioning itself as a forerunner in delivering early and accurate diagnosis for disease management.

Entities:  

Keywords:  PRM; dengue; diagnostics; flavivirus; targeted proteomics

Mesh:

Substances:

Year:  2019        PMID: 30886083      PMCID: PMC6452653          DOI: 10.1073/pnas.1817867116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction.

Authors:  R S Lanciotti; C H Calisher; D J Gubler; G J Chang; A V Vorndam
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

Review 2.  Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward.

Authors:  Bruno Guy; Olivier Briand; Jean Lang; Melanie Saville; Nicholas Jackson
Journal:  Vaccine       Date:  2015-10-20       Impact factor: 3.641

3.  Mass spectrometry-based proteomics in cancer research.

Authors:  William C Cho
Journal:  Expert Rev Proteomics       Date:  2017-08-21       Impact factor: 3.940

4.  Targeted proteomic quantification on quadrupole-orbitrap mass spectrometer.

Authors:  Sebastien Gallien; Elodie Duriez; Catharina Crone; Markus Kellmann; Thomas Moehring; Bruno Domon
Journal:  Mol Cell Proteomics       Date:  2012-09-07       Impact factor: 5.911

5.  Cost-effective real-time reverse transcriptase PCR (RT-PCR) to screen for Dengue virus followed by rapid single-tube multiplex RT-PCR for serotyping of the virus.

Authors:  Yee-Ling Lai; Youne-Kow Chung; Hwee-Cheng Tan; Hoon-Fang Yap; Grace Yap; Eng-Eong Ooi; Lee-Ching Ng
Journal:  J Clin Microbiol       Date:  2007-01-10       Impact factor: 5.948

6.  Culex flavivirus and West Nile virus mosquito coinfection and positive ecological association in Chicago, United States.

Authors:  Christina M Newman; Francesco Cerutti; Tavis K Anderson; Gabriel L Hamer; Edward D Walker; Uriel D Kitron; Marilyn O Ruiz; Jeffery D Brawn; Tony L Goldberg
Journal:  Vector Borne Zoonotic Dis       Date:  2011-01-22       Impact factor: 2.133

7.  Targeted Proteomics Identifies Proteomic Signatures in Liquid Biopsies of the Endometrium to Diagnose Endometrial Cancer and Assist in the Prediction of the Optimal Surgical Treatment.

Authors:  Elena Martinez-Garcia; Antoine Lesur; Laura Devis; Silvia Cabrera; Xavier Matias-Guiu; Marc Hirschfeld; Jasmin Asberger; Jan van Oostrum; María de Los Ángeles Casares de Cal; Antonio Gómez-Tato; Jaume Reventos; Bruno Domon; Eva Colas; Antonio Gil-Moreno
Journal:  Clin Cancer Res       Date:  2017-08-08       Impact factor: 12.531

8.  A semi-automated mass spectrometric immunoassay coupled to selected reaction monitoring (MSIA-SRM) reveals novel relationships between circulating PCSK9 and metabolic phenotypes in patient cohorts.

Authors:  Marie-Soleil Gauthier; Joëlle R Pérusse; Zuhier Awan; Annie Bouchard; Sylvain Tessier; Josée Champagne; Bryan Krastins; Gregory Byram; Katherine Chabot; Pierre Garneau; Rémi Rabasa-Lhoret; Denis Faubert; Mary F Lopez; Nabil G Seidah; Benoit Coulombe
Journal:  Methods       Date:  2015-03-11       Impact factor: 3.608

9.  Clinical and virological factors influencing the performance of a NS1 antigen-capture assay and potential use as a marker of dengue disease severity.

Authors:  Veasna Duong; Sowath Ly; Patrich Lorn Try; Anne Tuiskunen; Sivuth Ong; Norith Chroeung; Ake Lundkvist; Isabelle Leparc-Goffart; Vincent Deubel; Sirenda Vong; Philippe Buchy
Journal:  PLoS Negl Trop Dis       Date:  2011-07-19

10.  2016 update of the PRIDE database and its related tools.

Authors:  Juan Antonio Vizcaíno; Attila Csordas; Noemi del-Toro; José A Dianes; Johannes Griss; Ilias Lavidas; Gerhard Mayer; Yasset Perez-Riverol; Florian Reisinger; Tobias Ternent; Qing-Wei Xu; Rui Wang; Henning Hermjakob
Journal:  Nucleic Acids Res       Date:  2015-11-02       Impact factor: 16.971

View more
  7 in total

1.  Purple: A Computational Workflow for Strategic Selection of Peptides for Viral Diagnostics Using MS-Based Targeted Proteomics.

Authors:  Johanna Lechner; Felix Hartkopf; Pauline Hiort; Andreas Nitsche; Marica Grossegesse; Joerg Doellinger; Bernhard Y Renard; Thilo Muth
Journal:  Viruses       Date:  2019-06-08       Impact factor: 5.048

2.  Flavivirus Cross-Reactivity to Dengue Nonstructural Protein 1 Antigen Detection Assays.

Authors:  Li Kiang Tan; Wing Yan Wong; Hui Ting Yang; Roland G Huber; Peter J Bond; Lee Ching Ng; Sebastian Maurer-Stroh; Hapuarachchige Chanditha Hapuarachchi
Journal:  Diagnostics (Basel)       Date:  2019-12-24

Review 3.  A high-stringency blueprint of the human proteome.

Authors:  Subash Adhikari; Edouard C Nice; Eric W Deutsch; Lydie Lane; Gilbert S Omenn; Stephen R Pennington; Young-Ki Paik; Christopher M Overall; Fernando J Corrales; Ileana M Cristea; Jennifer E Van Eyk; Mathias Uhlén; Cecilia Lindskog; Daniel W Chan; Amos Bairoch; James C Waddington; Joshua L Justice; Joshua LaBaer; Henry Rodriguez; Fuchu He; Markus Kostrzewa; Peipei Ping; Rebekah L Gundry; Peter Stewart; Sanjeeva Srivastava; Sudhir Srivastava; Fabio C S Nogueira; Gilberto B Domont; Yves Vandenbrouck; Maggie P Y Lam; Sara Wennersten; Juan Antonio Vizcaino; Marc Wilkins; Jochen M Schwenk; Emma Lundberg; Nuno Bandeira; Gyorgy Marko-Varga; Susan T Weintraub; Charles Pineau; Ulrike Kusebauch; Robert L Moritz; Seong Beom Ahn; Magnus Palmblad; Michael P Snyder; Ruedi Aebersold; Mark S Baker
Journal:  Nat Commun       Date:  2020-10-16       Impact factor: 14.919

Review 4.  Advances in rapid detection of SARS-CoV-2 by mass spectrometry.

Authors:  Tsz-Fung Wong; Pui-Kin So; Zhong-Ping Yao
Journal:  Trends Analyt Chem       Date:  2022-08-20       Impact factor: 14.908

5.  Rational Design and Development of SARS-CoV-2 Serological Diagnostics by Immunoprecipitation-Targeted Proteomics.

Authors:  Zhiqiang Fu; Yasmine Rais; Delaram Dara; Dana Jackson; Andrei P Drabovich
Journal:  Anal Chem       Date:  2022-09-12       Impact factor: 8.008

6.  Perspective on Proteomics for Virus Detection in Clinical Samples.

Authors:  Marica Grossegesse; Felix Hartkopf; Andreas Nitsche; Lars Schaade; Joerg Doellinger; Thilo Muth
Journal:  J Proteome Res       Date:  2020-10-22       Impact factor: 4.466

Review 7.  Utility of Proteomics in Emerging and Re-Emerging Infectious Diseases Caused by RNA Viruses.

Authors:  Maike Sperk; Robert van Domselaar; Jimmy Esneider Rodriguez; Flora Mikaeloff; Beatriz Sá Vinhas; Elisa Saccon; Anders Sönnerborg; Kamal Singh; Soham Gupta; Ákos Végvári; Ujjwal Neogi
Journal:  J Proteome Res       Date:  2020-10-23       Impact factor: 4.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.